atopic dermatitis tagged posts

Key driver of Atopic Dermatitis discovered

Periostin (shown in pink) is being used in the clinic as a marker for allergic diseases such as asthma as well as atopic dermatitis. Left image: Periostin is overexpressed in atopic dermatitis. Right image: Blocking LIGHT also blocks periostin expression.

Periostin (shown in pink) is being used in the clinic as a marker for allergic diseases such as asthma as well as atopic dermatitis. Left image: Periostin is overexpressed in atopic dermatitis. Right image: Blocking LIGHT also blocks periostin expression.

Finding provides a novel therapeutic target for the treatment of severe eczema, a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes skin inflammation in atopic dermatitis and the characteristic thickening of the skin...

Read More

New Treatments help those with Mild, Moderate and Severe Eczema

eczema

Two new medications have recently been approved for atopic dermatitis (AD).

Although many adults with atopic dermatitis (eczema) develop the disease in childhood and carry it through life, a large number are first diagnosed in adulthood. “Atopic dermatitis (AD) is underdiagnosed in the United States,” says allergist Luz Fonacier, MD, ACAAI board member and presenter at the meeting. “Many adults don’t seek out medical care, preferring to self-treat instead, either with home remedies or over-the-counter drugs. Often, they aren’t aware they have eczema, and they also don’t know treatments have changed a lot in the last few years. There are new drugs and topical medications that can make a huge difference in their quality of life.”

In addition to the itching and discomfort, people with eczema ...

Read More

Single-gene Mutations that lead to Atopic Dermatitis identified

Child with eczema

Eczema, or atopic dermatitis, is an inflammatory skin condition that affects an estimated 30 percent of the U.S. population, mostly children and adolescents.NIAID

Researchers have identified mutations in a gene called CARD11 that lead to atopic dermatitis, or eczema, an allergic skin disease. Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and other institutions discovered the mutations in four unrelated families with severe atopic dermatitis and studied the resulting cell-signaling defects that contribute to allergic disease. Their findings, reported in Nature Genetics, also suggest that some of these defects potentially could be corrected by supplementation with the amino acid glutamine.

The scientists analyzed the genetic sequences of patients with severe atopic dermatitis and identified 8 individuals from four families with mutations in the CARD11 gene, which provides instructions for production of a cell-signaling protein of the same name. While some people with these mutations had other health issues, such as infections, others did not, implying that mutations in CARD11 could cause atopic dermatitis without leading to other medical issues often found in severe immune system syndromes.

Each of the four families had a distinct mutation that affected a different region of the CARD11 protein, but all the mutations had similar effects on T-cell signaling. With cell culture and other laboratory experiments, the researchers determined that the mutations led to defective activation of two cell-signaling pathways, one of which typically is activated in part by glutamine.

Growing cultured T cells from patients with CARD11 mutations with excess glutamine boosted mTORC1 activation, a key part of one of the affected pathways, suggesting the potential to partially correct the cell-signaling defects that may contribute to atopic dermatitis. The scientists now are planning a study to assess the effect of supplemental glutamine and leucine, another amino acid that activates mTORC1, in people with atopic dermatitis with and without CARD11 mutations.
https://www.nih.gov/news-events/news-releases/scientists-identify-single-gene-mutations-lead-atopic-dermatitis

Read More

Vitamin D levels Not Linked to Asthma or Dermatitis

Vitamin D production

Vitamin D production

Vitamin D supplementation is unlikely to reduce the risk of asthma in children or adults, atopic dermatitis, or allergies according to a new study published in PLOS Medicine by Brent Richards, of McGill University, Canada, and the Lady Davis Institute at the Jewish General Hospital, Canada, and colleagues. Some previous epidemiological studies have suggested that low vitamin D levels are associated with increased rates of asthma, atopic dermatitis and elevated levels of IgE. In the new work, researchers looked at genetic and health data on more than 100,000 individuals from previous large studies to determine whether genetic alterations that are associated with vitamin D levels predispose people to asthma, dermatitis, or high IgE levels.

The researchers found no statis...

Read More